title: Development of HIF-1 inhibitors for cancer therapy.
abstract: Intratumour hypoxia has long been considered a driving force of tumour progression and a negative prognostic factor in human cancers. The discovery of hypoxia inducible factors (HIFs), which mediate transcriptional responses to changes in oxygen levels, has renewed enthusiasm for the discovery and development of targeted therapies exploiting the hypoxic tumour microenvironment. In spite of an ever increasing number of putative small molecule inhibitors of HIF, only few progress through pre-clinical and early clinical development. In this review, we will focus primarily on: (1) HIF inhibitors that have been more recently described and (2) small molecules targeting HIF that are being tested in early clinical trials or that are already approved for use in patients. A rigorous 'validation' of HIF targeted therapies in relevant pre-clinical models and eventually in pharmacodynamic-based early clinical trials is essential for 'credentialing' HIF-1 as a legitimate target that can be pharmacologically modulated in cancer patients.
authors.affiliation: Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, Frederick, MD 21702-1201, USA.
authors.forename: Barbara
authors.initials: B
authors.lastname: Onnis
authors.forename: Annamaria
authors.initials: A
authors.lastname: Rapisarda
authors.forename: Giovanni
authors.initials: G
authors.lastname: Melillo
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D055808:Drug Discovery; D006801:Humans; D051793:Hypoxia-Inducible Factor 1 / Q000037:antagonists & inhibitors*; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D051793:Hypoxia-Inducible Factor 1
references.citation: J Biol Chem. 1997 Sep 5;272(36):22642-7
references.pmid: 9278421
references.citation: Nat Rev Drug Discov. 2003 Oct;2(10):803-11
references.pmid: 14526383
references.citation: J Nat Prod. 2009 May 22;72(5):805-12
references.pmid: 19405508
references.citation: Biochem Biophys Res Commun. 1995 Nov 13;216(2):669-75
references.pmid: 7488163
references.citation: Drug Discov Today. 2007 Oct;12(19-20):853-9
references.pmid: 17933687
references.citation: Clin Cancer Res. 2007 Feb 1;13(3):1010-8
references.pmid: 17289897
references.citation: Mol Cell Biol. 2009 Apr;29(8):2243-53
references.pmid: 19223463
references.citation: Anticancer Res. 2003 Mar-Apr;23(2C):1673-80
references.pmid: 12820439
references.citation: Blood. 2002 Nov 15;100(10):3767-75
references.pmid: 12393646
references.citation: Genes Dev. 2000 Feb 15;14(4):391-6
references.pmid: 10691731
references.citation: J Biol Chem. 2008 Jun 13;283(24):16309-19
references.pmid: 18430730
references.citation: Cancer Control. 2003 Sep-Oct;10(5):361-9
references.pmid: 14581890
references.citation: Cancer. 2009 Aug 15;115(16):3618-30
references.pmid: 19479976
references.citation: Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2353-8
references.pmid: 19168635
references.citation: Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5510-4
references.pmid: 7539918
references.citation: Clin Cancer Res. 2007 Jan 15;13(2 Pt 2):680s-684s
references.pmid: 17255293
references.citation: Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19579-86
references.pmid: 19020076
references.citation: Mol Cancer Ther. 2008 Jan;7(1):90-100
references.pmid: 18202012
references.citation: Methods Enzymol. 2007;435:385-402
references.pmid: 17998065
references.citation: Cancer Lett. 2009 Aug 8;280(2):145-53
references.pmid: 19111391
references.citation: Mol Cancer Ther. 2003 Mar;2(3):235-43
references.pmid: 12657718
references.citation: Mol Cell Biol. 2006 Aug;26(15):5895-907
references.pmid: 16847340
references.citation: Mol Cell Biol. 2001 Jun;21(12):3995-4004
references.pmid: 11359907
references.citation: Cancer Res. 2004 Feb 15;64(4):1475-82
references.pmid: 14983893
references.citation: Clin Cancer Res. 2005 Aug 1;11(15):5526-33
references.pmid: 16061869
references.citation: Nat Med. 2004 Jun;10(6):594-601
references.pmid: 15156201
references.citation: J Biosci. 2007 Apr;32(3):517-30
references.pmid: 17536171
references.citation: Cancer Invest. 2004;22(2):304-11
references.pmid: 15199612
references.citation: Blood. 2008 Mar 15;111(6):3131-6
references.pmid: 18174379
references.citation: J Natl Cancer Inst. 2005 Sep 7;97(17):1272-86
references.pmid: 16145048
references.citation: Mol Cancer Ther. 2009 Jul;8(7):1867-77
references.pmid: 19584228
references.citation: Neuro Oncol. 2005 Jul;7(3):225-35
references.pmid: 16053697
references.citation: Mol Pharmacol. 2002 Nov;62(5):975-82
references.pmid: 12391259
references.citation: Cancer Cell. 2004 Jul;6(1):33-43
references.pmid: 15261140
references.citation: Nat Rev Cancer. 2004 Jun;4(6):437-47
references.pmid: 15170446
references.citation: Proc Natl Acad Sci U S A. 2004 Nov 30;101(48):16768-73
references.pmid: 15556999
references.citation: Mol Cancer Ther. 2008 Nov;7(11):3598-608
references.pmid: 18974394
references.citation: Clin Cancer Res. 2008 Mar 15;14(6):1888-96
references.pmid: 18347192
references.citation: J Biol Chem. 2002 Aug 16;277(33):29936-44
references.pmid: 12052835
references.citation: Cancer Res. 2004 Oct 1;64(19):6845-8
references.pmid: 15466170
references.citation: Oncogene. 2005 Jun 23;24(27):4433-41
references.pmid: 15806152
references.citation: Curr Top Med Chem. 2006;6(11):1163-71
references.pmid: 16842153
references.citation: Lancet. 2008 Aug 9;372(9637):449-56
references.pmid: 18653228
references.citation: Nat Rev Cancer. 2008 Nov;8(11):851-64
references.pmid: 18846101
references.citation: Cancer Metastasis Rev. 2007 Jun;26(2):341-52
references.pmid: 17415529
references.citation: Cancer Res. 2006 Jun 1;66(11):5549-54
references.pmid: 16740688
references.citation: Mol Cancer Ther. 2004 Mar;3(3):233-44
references.pmid: 15026543
references.citation: Neoplasia. 2006 May;8(5):394-401
references.pmid: 16790088
references.citation: Cancer Cell. 2003 Apr;3(4):363-75
references.pmid: 12726862
references.citation: Science. 2009 Jun 5;324(5932):1289-93
references.pmid: 19498162
references.citation: Nat Med. 2006 Jan;12(1):122-7
references.pmid: 16341243
references.citation: Cancer Res. 2005 Oct 1;65(19):9047-55
references.pmid: 16204079
references.citation: J Clin Oncol. 2002 Jan 1;20(1):289-96
references.pmid: 11773181
references.citation: Biochem Biophys Res Commun. 2003 Feb 28;302(1):95-100
references.pmid: 12593853
references.citation: Cancer Res. 2002 Aug 1;62(15):4316-24
references.pmid: 12154035